GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator’s choice of treatment in patients with recurrent low grade serous ovarian cancer
| Image |  |
|---|---|
| Description | scientific article published on 7 October 2024 |
| Author/s |
author: Mansoor Raza Mirza David Gershenson Els Van Nieuwenhuysen Ana Oaknin Susana Banerjee Kathleen N. Moore Rachel N. Grisham Bradley J. Monk |
| Publication date | October 7, 2024 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |